An 'elegant' idea proves its worth 25 years later

May 31, 2007

The simple notion of copying the body’s own natural "waste disposal" chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders --- most of them children – according to a report in this week’s New England Journal of Medicine summarizing a quarter century of experience with the treatment.

The effectiveness of sodium phenylacetate and sodium benzoate, two chemicals the body already makes to carry nitrogen for disposal in urine "just knocked my socks off from the moment we first tried them," recalls Saul Brusilow, M.D., professor emeritus of pediatrics at Hopkins who first had the notion to use the drugs. "In all my years I never came across another disease where patients come in near-comatose and you stick a needle in them and lo and behold, they wake up—just like that. It was just astonishing," he says.

"His elegant idea was to give patients chemicals they already make in small amounts in large doses to make up for the missing urea cycle enzyme they inherited," says Ada Hamosh, M.D., M.P.H, clinical director of the McKusick-Nathans Institute of Genetic Medicine. "Sodium phenylacetate and sodium benzoate already know how to eliminate nitrogen in urine, so having more in the body carries more nitrogen out and reduces the toxic effects of excess nitrogen accumulation."

Excess nitrogen yields ammonia, which is poisonous and in the case of urea cycle disorders, causes brain damage, retardation, coma and even death.

Despite the immediate clinical success of the treatment, the drug combination was finally approved by the U.S. Food and Drug Administration only in 2005.

Brusilow, Hamosh, and colleagues at Stanford University, University of Minnesota, Thomas Jefferson University and the Medical College of Wisconsin looked back at 299 urea cycle disorder patients with a total of 1,181 hyperammonemia "episodes" from 118 hospitals around the United States from August 1980 until March 2005.

The regimen consisted of high-dose intravenous sodium phenylacetate and sodium benzoate for two hours followed by "maintenance infusions" until blood ammonia levels were normal. The patients’ overall survival rate was 84 percent, and 96 percent survived episodes of severe ammonia poisoning.

An estimated one in 40,000 live births is a child with a urea cycle disorder, according to Hamosh, who says early and accurate detection can now assure prompt treatment.

"We’re teaching all medical students at Hopkins to consider hyperammonemia and immediately do blood tests when they see a combative, lethargic or comatose newborn or child," she says. "The longer the hyperammonemia lasts, the higher the risk for brain damage."

"This is a happy story," says Brusilow. "It isn’t too often in genetic medicine that we can intuitively develop a treatment with already available chemicals and save lives."


Source: Johns Hopkins Medical Institutions

Explore further: Merck completes sale of consumer unit to Bayer

add to favorites email to friend print save as pdf

Related Stories

Battling climate change with tried-and-true methods

Mar 29, 2013

For decades, farmers in Montana and the Dakotas have produced impressive yields of barley and wheat. But that bounty has come at a cost. Tilling the soil in the region's crop-fallow production systems has ...

Salt seeds clouds in the Amazon rainforest

Sep 10, 2012

It's morning, deep in the Amazon jungle. In the still air innumerable leaves glisten with moisture, and fog drifts through the trees. As the sun rises, clouds appear and float across the forest canopy ... ...

'Trophy molecule' breakthrough

Jun 29, 2012

Experts at The University of Nottingham are the first to create a stable version of a ‘trophy molecule’ that has eluded scientists for decades.

The methane habitable zone

Nov 11, 2011

In the search for life elsewhere, many studies focus on finding liquid water. But what if life could exist with some other solvent? Saturn’s smoggy moon Titan makes scientists question the possibilities ...

LED streetlights best buy for cities, researchers report

Mar 08, 2010

University of Pittsburgh researchers have conducted the first cradle-to-grave assessment of light-emitting diode (LED) streetlights and determined that the increasingly popular lamps strike the best balance between brightness, ...

Recommended for you

Merck completes sale of consumer unit to Bayer

1 hour ago

Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...

Viagra ads target women for first time

Sep 30, 2014

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.

User comments : 0